Latest New Zealand News

Latrobe Magnesium Limited has announced a fully underwritten $10 million equity raise through a $6 million placement and a $4 million rights issue to fund its magnesium production expansion. The capital will support the commissioning of its Demonstration Plant and advance plans for a 10,000 tonne commercial facility.

Clara Resources Australia Limited has announced a fully underwritten entitlement offer to raise approximately $1.27 million, aimed at funding drilling and development activities at its Ashford Coking Coal project. The offer follows a recent placement and includes a shortfall facility for eligible shareholders.

Cleanaway Waste Management reaffirms its FY26 earnings guidance despite a slow start to the year and unveils plans for an indirect cost reduction program aimed at boosting efficiency.

Jindalee Lithium has successfully raised $8 million through a private placement, complemented by a $1 million Share Purchase Plan, to advance its McDermitt Lithium Project and a strategic US SPAC transaction.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Zip Co Limited has increased its on-market share buy-back limit from $50 million to $100 million, reflecting confidence in its financial strength and growth prospects. The move underscores the company’s commitment to capital management and shareholder returns.

Zip Co Limited has reported a near doubling in cash earnings for Q1 FY26, driven by robust transaction growth and improved operating leverage, particularly in the US market. The company also doubled its share buy-back program and raised its US transaction volume growth guidance.

Reece Limited has completed a $365 million off-market share buy-back, repurchasing 4.3% of its shares at $13 each with no scale-back applied. This move returns excess capital to shareholders while preserving financial flexibility for future growth.